Article
The metastatic capacity of high-grade serous ovarian cancer cells changes along disease progression: inhibition by mifepristone
2022-05-07
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Background</h4> Reductionist two-dimensional (2D) in vitro assays have long been the standard for studying the metastatic abilities of cancer cells. However, tri-dimensional (3D) organotypic models provide a more complex environment, closer to that seen in patients, and thereby provide a more accurate representation of their true capabilities. Our laboratory has previously shown that the an...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0ad73eb2-149c-5560-a09b-f5758dfcb650
- DOI
- 10.1101/2022.05.07.491021
